Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 22, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

Drug-eluting stent in malignant biliary obstruction.

Dong Ki Lee1

  • 1Department of Internal Medicine, Kangnam Hospital, Yonsei University, P.O. Box 1217, Kangnam, Seoul, Korea. dklee@yuhs.ac

Journal of Hepato-Biliary-Pancreatic Surgery
|June 26, 2009
PubMed
Summary

Drug-eluting stents (DES) show promise for malignant bile duct obstruction, potentially offering anti-tumor effects beyond mechanical palliation. Further research is needed to confirm their efficacy and improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hetero-Solvent Microenvironment for Selective CO<sub>2</sub> to Ethanol Electrolysis via Interfacial Water Control.

Nano-micro letters·2026
Same author

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Economic Low-Carbon Chemical Production via Paired Electrolysis of Carbon Monoxide (CO) and 5-hydroxymethylfurfural (HMF).

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Adherent-to-suspension transition modulates circulating tumor cell dynamics and metastatic potential in melanoma.

Molecules and cells·2026
Same author

Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer.

Genome biology·2026
Same author

Efficacy of fully covered self-expanding metal stents removal versus stent-in-stent techniques in recurrent malignant distal biliary obstruction.

Scientific reports·2026

Area of Science:

  • Gastroenterology
  • Oncology
  • Biomedical Engineering

Background:

  • Malignant bile duct obstruction often requires endoscopic stent insertion for palliation.
  • Current stents provide mechanical relief but lack anti-tumor properties.
  • Drug-eluting stents (DES) are highly effective in vascular applications.

Purpose of the Study:

  • To explore the potential of non-vascular drug-eluting stents (DES) for malignant bile duct obstruction.
  • To investigate DES capabilities in suppressing tumor proliferation and mucosal hyperplasia in the bile duct.
  • To assess the feasibility of adapting vascular DES technology for non-vascular applications.

Main Methods:

  • Designing non-vascular DES with membranes for gradual chemo-agent release.
  • Evaluating anti-tumor agents through ongoing animal and human studies.

More Related Videos

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
08:26

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

Related Experiment Videos

Last Updated: Jun 22, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
08:26

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

  • Adapting DES technology for the unique challenges of the bile duct environment.

    • Main Results:

    • The study is in the investigation phase, with ongoing animal and human trials.
    • Requirements for non-vascular DES differ significantly from vascular DES.
    • The potential for chemo-agent release from a membrane-covered stent is being explored.

    Conclusions:

    • Drug-eluting stents (DES) hold promise for treating malignant bile duct obstruction by offering anti-tumor effects.
    • Successful implementation of DES could prolong stent patency and patient survival.
    • Extensive investigation and clinical studies are necessary to validate DES efficacy in the bile duct.